• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 住院实体器官移植患者的普通和重症监护结局。

General and Intensive Care Outcomes for Hospitalized Patients With Solid Organ Transplants With COVID-19.

机构信息

Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, 232890Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Northwell Health, New York, NY, USA.

5925Icahn School of Medicine at Mount Sinai, New York, NY, USA.

出版信息

J Intensive Care Med. 2021 Apr;36(4):494-499. doi: 10.1177/0885066620965163. Epub 2020 Oct 9.

DOI:10.1177/0885066620965163
PMID:33034239
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7548542/
Abstract

PURPOSE

COVID-19 has been associated with a dysregulated inflammatory response. Patients who have received solid-organ transplants are more susceptible to infections in general due to the use of immunosuppressants. We investigated factors associated with mechanical ventilation and outcomes in solid-organ transplant recipients with COVID-19.

MATERIALS AND METHODS

We conducted a retrospective cohort study of all solid-organ transplant recipients admitted with a diagnosis of COVID-19 in our 23-hospital health system over a 1-month period. Descriptive statistics were used to describe hospital course and laboratory results and bivariate comparisons were performed on variables to determine differences.

RESULTS

Twenty-two patients with solid-organ transplants and COVID-19 were identified. Eight patients were admitted to the ICU, of which 7 were intubated. Admission values of CRP (p = 0.045) and N/L ratio (p = 0.047) were associated with the need for mechanical ventilation. Seven patients (32%) died during admission, including 86% (n = 6) of patients who received mechanical ventilation.

CONCLUSIONS

In solid-organ transplant recipients with COVID-19, initial CRP and N/L ratio were associated with need for mechanical ventilation.

摘要

目的

COVID-19 与失调的炎症反应有关。由于使用免疫抑制剂,接受过实体器官移植的患者通常更容易受到感染。我们研究了与 COVID-19 实体器官移植受者机械通气和结局相关的因素。

材料和方法

我们对在我们的 23 家医院医疗系统中因 COVID-19 住院的所有实体器官移植受者进行了回顾性队列研究,为期 1 个月。使用描述性统计来描述住院过程和实验室结果,并对变量进行双变量比较以确定差异。

结果

确定了 22 例患有 COVID-19 的实体器官移植受者。8 例患者入住 ICU,其中 7 例插管。入院时 CRP(p = 0.045)和 N/L 比值(p = 0.047)与机械通气的需要相关。7 名患者(32%)在住院期间死亡,其中接受机械通气的患者占 86%(n = 6)。

结论

在患有 COVID-19 的实体器官移植受者中,初始 CRP 和 N/L 比值与机械通气的需要相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1e4/7944427/1e1e1efd088a/10.1177_0885066620965163-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1e4/7944427/1e1e1efd088a/10.1177_0885066620965163-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1e4/7944427/1e1e1efd088a/10.1177_0885066620965163-fig1.jpg

相似文献

1
General and Intensive Care Outcomes for Hospitalized Patients With Solid Organ Transplants With COVID-19.COVID-19 住院实体器官移植患者的普通和重症监护结局。
J Intensive Care Med. 2021 Apr;36(4):494-499. doi: 10.1177/0885066620965163. Epub 2020 Oct 9.
2
COVID-19 in solid organ transplant recipients: Dynamics of disease progression and inflammatory markers in ICU and non-ICU admitted patients.实体器官移植受者中的新冠病毒肺炎:入住重症监护病房和未入住重症监护病房患者的疾病进展动态及炎症标志物
Transpl Infect Dis. 2020 Oct;22(5):e13407. doi: 10.1111/tid.13407. Epub 2020 Jul 22.
3
COVID-19 in solid organ transplant recipients: Initial report from the US epicenter.COVID-19 于实体器官移植受者:来自美国震中地区的初步报告。
Am J Transplant. 2020 Jul;20(7):1800-1808. doi: 10.1111/ajt.15941. Epub 2020 May 10.
4
A propensity score-matched analysis of mortality in solid organ transplant patients with COVID-19 compared to non-solid organ transplant patients.一项与非实体器官移植患者相比 COVID-19 实体器官移植患者死亡率的倾向评分匹配分析。
PLoS One. 2021 Mar 3;16(3):e0247251. doi: 10.1371/journal.pone.0247251. eCollection 2021.
5
The inflammatory biomarkers profile of hospitalized patients with COVID-19 and its association with patient's outcome: A single centered study.COVID-19 住院患者的炎症生物标志物特征及其与患者预后的关系:一项单中心研究。
PLoS One. 2021 Dec 2;16(12):e0260537. doi: 10.1371/journal.pone.0260537. eCollection 2021.
6
Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy.重症监护治疗新型冠状病毒 SARS-CoV-2 感染患者:意大利克雷马医院的经验。
Am J Emerg Med. 2021 Jul;45:156-161. doi: 10.1016/j.ajem.2020.08.005. Epub 2020 Aug 16.
7
SARS-CoV-2 / COVID-19 in patients on the Swiss national transplant waiting list.瑞士全国移植等待名单上的 SARS-CoV-2/COVID-19 患者。
Swiss Med Wkly. 2020 Dec 31;150:w20451. doi: 10.4414/smw.2020.20451. eCollection 2020 Dec 14.
8
Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study.实体器官移植受者感染甲型 H1N1 流感的结局:一项多中心队列研究。
Lancet Infect Dis. 2010 Aug;10(8):521-6. doi: 10.1016/S1473-3099(10)70133-X. Epub 2010 Jul 9.
9
Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study.肝移植受者感染 SARS-CoV-2 后的结局:一项国际注册研究。
Lancet Gastroenterol Hepatol. 2020 Nov;5(11):1008-1016. doi: 10.1016/S2468-1253(20)30271-5. Epub 2020 Aug 28.
10
Clinical Features of SARS-CoV-2 Infection in Patients Undergoing Solid-Organ Transplant: Baskent University Experience.实体器官移植患者中新型冠状病毒2型感染的临床特征:巴斯肯特大学经验
Exp Clin Transplant. 2023 May;21(5):451-459. doi: 10.6002/ect.2021.0361. Epub 2021 Oct 11.

引用本文的文献

1
Clinical manifestations and outcomes of coronavirus disease-19 in heart transplant recipients: a multicentre case series with a systematic review and meta-analysis.COVID-19 在心脏移植受者中的临床表现和结局:一项多中心病例系列研究及系统评价和荟萃分析。
Transpl Int. 2021 Apr;34(4):721-731. doi: 10.1111/tri.13837. Epub 2021 Mar 5.

本文引用的文献

1
Outcomes of critically ill solid organ transplant patients with COVID-19 in the United States.美国 COVID-19 危重症实体器官移植患者的结局。
Am J Transplant. 2020 Nov;20(11):3061-3071. doi: 10.1111/ajt.16280. Epub 2020 Sep 15.
2
Effect of Systemic Glucocorticoids on Mortality or Mechanical Ventilation in Patients With COVID-19.COVID-19 患者全身糖皮质激素治疗对死亡率或机械通气的影响。
J Hosp Med. 2020 Aug;15(8):489-493. doi: 10.12788/jhm.3497.
3
Dexamethasone in Hospitalized Patients with Covid-19.地塞米松在 COVID-19 住院患者中的应用。
N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.
4
Remdesivir for the Treatment of Covid-19 - Preliminary Report. Reply.瑞德西韦治疗新冠病毒病-初步报告。回复。
N Engl J Med. 2020 Sep 3;383(10):994. doi: 10.1056/NEJMc2022236. Epub 2020 Jul 10.
5
Early Experience With COVID-19 and Solid Organ Transplantation at a US High-volume Transplant Center.美国一家大容量移植中心的 COVID-19 与实体器官移植的早期经验。
Transplantation. 2020 Nov;104(11):2208-2214. doi: 10.1097/TP.0000000000003339.
6
Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial.恢复期血浆疗法对重症和危及生命的 COVID-19 患者临床改善时间的影响:一项随机临床试验。
JAMA. 2020 Aug 4;324(5):460-470. doi: 10.1001/jama.2020.10044.
7
First cases of COVID-19 in heart transplantation from China.中国心脏移植中首例新冠病毒病病例。
J Heart Lung Transplant. 2020 May;39(5):496-497. doi: 10.1016/j.healun.2020.03.006. Epub 2020 Mar 17.
8
COVID-19 in kidney transplant recipients.肾移植受者中的 COVID-19 。
Am J Transplant. 2020 Jul;20(7):1819-1825. doi: 10.1111/ajt.15967. Epub 2020 May 27.
9
COVID-19 in solid organ transplant recipients: Initial report from the US epicenter.COVID-19 于实体器官移植受者:来自美国震中地区的初步报告。
Am J Transplant. 2020 Jul;20(7):1800-1808. doi: 10.1111/ajt.15941. Epub 2020 May 10.
10
Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study.淋巴细胞减少症可预测新型冠状病毒肺炎的疾病严重程度:一项描述性和预测性研究。
Signal Transduct Target Ther. 2020 Mar 27;5(1):33. doi: 10.1038/s41392-020-0148-4.